Filing Details
- Accession Number:
- 0001179110-10-016805
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-02 12:01:13
- Reporting Period:
- 2010-11-30
- Filing Date:
- 2010-12-02
- Accepted Time:
- 2010-12-02 12:01:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411158 | Anacor Pharmaceuticals Inc | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
905088 | I Trust Management Rho | C/O Rho Capital Partners, Inc. 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
943431 | Joshua Ruch | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1020455 | Rho Capital Partners Inc | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1082907 | Habib Kairouz | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1126016 | Rho Ventures Iv Lp | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1126022 | Rho Ventures Iv Qp Lp | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1269064 | Rho Management Ventures Iv Llc | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1269066 | Rho Ventures Iv Gmbh & Co Beteiligungs Kg | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No | |
1269068 | Gmbh Verwaltungs Partners Capital Rho | 152 West 57Th Street, 23Rd Floor New York NY 10019 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-11-30 | 507,398 | $0.00 | 507,398 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-11-30 | 527,469 | $0.00 | 1,034,867 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-11-30 | 1,752,807 | $0.00 | 2,787,674 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-11-30 | 212,514 | $0.00 | 3,000,188 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-11-30 | 221,235 | $0.00 | 3,221,423 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2010-11-30 | 2,400,000 | $5.00 | 5,621,423 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A-1 Preferred Stock | Disposition | 2010-11-30 | 507,398 | $0.00 | 507,398 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2010-11-30 | 400,720 | $0.00 | 527,469 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2010-11-30 | 1,752,807 | $0.00 | 1,752,807 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2010-11-30 | 212,514 | $0.00 | 212,514 | $0.00 |
Common Stock | Series E Preferred Stock | Disposition | 2010-11-30 | 221,235 | $0.00 | 221,235 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Reflects the automatic conversion of each share of Preferred Stock into 1 share of Common Stock (other than the Series B Preferred Stock, which converted on a 1 to 1.316 basis) upon the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
- Consists of 63,531 shares held by Rho Ventures IV, L.P. ("RV IV"), 155,873 shares held by Rho Ventures IV GmbH & Co. Beteilgungs KG ("RV KG"), 149,569 shares held by Rho Ventures IV (QP), L.P. ("RV QP"), and 138,425 shares held by Rho Management Trust I ("RMT I").
- Consists of 66,044 shares held by RV IV, 162,038 shares held by RV KG, 155,486 shares held by RV QP, and 143,901 shares held by RMT I.
- Consists of 219,469 shares held by RV IV, 538,462 shares held by RV KG, 516,687 shares held by RV QP, and 478,189 shares held by RMT I.
- Consists of 26,609 shares held by RV IV, 65,284 shares held by RV KG, 62,644 shares held by RV QP, and 57,977 shares held by RMT I.
- Consists of 27,701 shares held by RV IV, 67,963 shares held by RV KG, 65,215 shares held by RV QP, and 60,356 shares held by RMT I.
- Consists of 300,505 shares held by RV IV, 737,280 shares held by RV KG, 707,463 shares held by RV QP, and 654,752 shares held by RMT I.
- Rho Management Ventures IV, L.L.C. ("RMV") is the general partner of RV IV and RV QP, Rho Capital Partners Verwaltungs GmbH ("RCP GmbH") is the general partner of RV KG, and Rho Capital Partners, Inc. ("RCP") is the investment advisor to RMT I. Each of RMV, RCP GmbH and RCP disclaims beneficial ownership of the reportable securities and this report shall not be deemed an admission that such filer is the beneficial owner of such securities, except to the extent of its pecuniary interest therein. Habib Kairouz and Joshua Ruch are managing members of RMV, managing directors of RCP GmbH and managing partners of RCP. Each of Habib Kairouz and Joshua Ruch disclaim beneficial ownership of the reportable securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities, except to the extent of his pecuniary interest therein.